Apollo Hospitals Enterprise Ltd
Apollo Hospitals was established in 1983 by Dr. Prathap C Reddy, renowned architect of modern healthcare in India. As the nation’s first corporate hospital, Apollo Hospitals is acclaimed for pioneering the private healthcare revolution in the country.
Apollo Hospitals has emerged as Asia’s foremost integrated healthcare services provider and has a robust presence across the healthcare ecosystem, including Hospitals, Pharmacies,
Primary Care & Diagnostic Clinics and several Retail Health models. #
Healthcare Business (53% of revenues)
Company's healthcare business has a capacity of 10,261 beds in 71 facilities located in India and overseas. Of the 71 facilities, 45 are self owned hospitals, 10 are cradles, 11 are day care/short surgical stay centres and 5 are hospitals under management.
Apollo Hospitals has facilities located in large urban centers such as Chennai, Hyderabad, Kolkata, Bengaluru, New Delhi, Ahmedabad, Mumbai, Pune, Bhubaneshwar, Madurai and Mysore among others. Presently, The company's facilities functions at comfortable utilization rates at around 69-70% #.
- Market Cap ₹ 43,741 Cr.
- Current Price ₹ 3,042
- High / Low ₹ 3,284 / 1,047
- Stock P/E 1,708
- Book Value ₹ 218
- Dividend Yield 0.20 %
- ROCE 14.3 %
- ROE 9.57 %
- Face Value ₹ 5.00
Pros
- Company has been maintaining a healthy dividend payout of 37.66%
- Company's median sales growth is 17.72% of last 10 years
Cons
- Stock is trading at 13.95 times its book value
- Company has low interest coverage ratio.
- Company has a low return on equity of 6.85% for last 3 years.
- Promoters have pledged 30.14% of their holding.
- Promoter holding has decreased over last 3 years: -3.56%
Peer comparison
Sector: Healthcare Industry: Healthcare
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Jun 2018 | Sep 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Dec 2020 | |
---|---|---|---|---|---|---|---|---|---|---|---|
2,210 | 2,412 | 2,495 | 2,500 | 2,572 | 2,841 | 2,912 | 2,922 | 2,172 | 2,761 | 2,760 | |
1,981 | 2,141 | 2,222 | 2,220 | 2,218 | 2,427 | 2,482 | 2,542 | 2,159 | 2,470 | 2,370 | |
Operating Profit | 229 | 271 | 273 | 280 | 354 | 413 | 430 | 380 | 13 | 291 | 390 |
OPM % | 10% | 11% | 11% | 11% | 14% | 15% | 15% | 13% | 1% | 11% | 14% |
Other Income | 5 | 3 | 12 | 23 | 10 | 9 | 10 | 203 | 8 | 47 | 21 |
Interest | 76 | 81 | 84 | 85 | 126 | 134 | 137 | 135 | 127 | 122 | 101 |
Depreciation | 95 | 97 | 98 | 105 | 144 | 155 | 157 | 164 | 160 | 149 | 125 |
Profit before tax | 63 | 96 | 103 | 112 | 94 | 134 | 145 | 284 | -267 | 66 | 185 |
Tax % | 63% | 44% | 52% | 35% | 48% | 38% | 38% | 26% | 15% | 10% | 28% |
Net Profit | 34 | 63 | 57 | 82 | 57 | 86 | 92 | 219 | -208 | 60 | 130 |
EPS in Rs | 2.44 | 4.56 | 4.10 | 5.87 | 4.11 | 6.20 | 6.62 | 15.77 | -14.96 | 4.33 | 9.38 |
Notes | Notes | Notes | Notes | Notes | Notes | Notes | Notes | Notes | Notes | Notes |
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1,614 | 2,026 | 2,605 | 3,148 | 3,769 | 4,357 | 5,129 | 6,150 | 7,256 | 8,243 | 9,617 | 11,247 | 10,614 | |
1,386 | 1,726 | 2,183 | 2,631 | 3,161 | 3,685 | 4,394 | 5,446 | 6,524 | 7,442 | 8,553 | 9,660 | 9,541 | |
Operating Profit | 228 | 301 | 422 | 516 | 608 | 672 | 735 | 704 | 731 | 801 | 1,064 | 1,587 | 1,074 |
OPM % | 14% | 15% | 16% | 16% | 16% | 15% | 14% | 11% | 10% | 10% | 11% | 14% | 10% |
Other Income | 16 | 32 | 12 | 23 | 36 | 21 | 50 | 72 | 62 | 25 | 31 | 225 | 278 |
Interest | 46 | 60 | 78 | 89 | 103 | 119 | 118 | 180 | 257 | 295 | 327 | 533 | 486 |
Depreciation | 63 | 75 | 95 | 124 | 142 | 168 | 212 | 264 | 314 | 359 | 396 | 620 | 599 |
Profit before tax | 134 | 198 | 261 | 326 | 399 | 407 | 455 | 332 | 222 | 171 | 373 | 660 | 268 |
Tax % | 36% | 34% | 33% | 35% | 26% | 25% | 29% | 29% | 41% | 65% | 47% | 34% | |
Net Profit | 102 | 138 | 184 | 219 | 304 | 317 | 340 | 236 | 221 | 117 | 236 | 455 | 202 |
EPS in Rs | 8.51 | 11.13 | 14.75 | 16.31 | 21.88 | 22.77 | 24.43 | 16.99 | 15.88 | 8.44 | 16.96 | 32.69 | 14.52 |
Dividend Payout % | 38% | 31% | 25% | 25% | 25% | 25% | 24% | 35% | 38% | 59% | 35% | 18% |
Compounded Sales Growth | |
---|---|
10 Years: | 19% |
5 Years: | 17% |
3 Years: | 16% |
TTM: | -2% |
Compounded Profit Growth | |
---|---|
10 Years: | 9% |
5 Years: | -0% |
3 Years: | 13% |
TTM: | -92% |
Stock Price CAGR | |
---|---|
10 Years: | 21% |
5 Years: | 17% |
3 Years: | 38% |
1 Year: | 76% |
Return on Equity | |
---|---|
10 Years: | 9% |
5 Years: | 7% |
3 Years: | 7% |
Last Year: | 10% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Sep 2020 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
60 | 62 | 62 | 67 | 70 | 70 | 70 | 70 | 70 | 70 | 70 | 70 | 70 | |
Reserves | 1,401 | 1,592 | 1,768 | 2,401 | 2,677 | 2,907 | 3,101 | 3,261 | 3,240 | 3,182 | 3,264 | 3,270 | 3,066 |
Borrowings | 671 | 913 | 957 | 817 | 1,213 | 1,344 | 1,992 | 2,834 | 3,125 | 3,427 | 3,673 | 3,596 | 3,270 |
493 | 675 | 815 | 698 | 854 | 1,029 | 1,297 | 1,195 | 1,668 | 1,917 | 2,159 | 4,354 | 3,903 | |
Total Liabilities | 2,624 | 3,242 | 3,602 | 3,983 | 4,814 | 5,350 | 6,459 | 7,360 | 8,103 | 8,596 | 9,166 | 11,289 | 10,309 |
1,044 | 1,322 | 1,530 | 2,011 | 2,341 | 2,681 | 3,244 | 3,997 | 4,591 | 4,773 | 4,982 | 7,432 | 6,490 | |
CWIP | 245 | 304 | 361 | 209 | 403 | 491 | 533 | 562 | 347 | 712 | 822 | 236 | 211 |
Investments | 591 | 417 | 502 | 564 | 527 | 322 | 311 | 352 | 406 | 352 | 462 | 434 | 365 |
745 | 1,200 | 1,210 | 1,198 | 1,543 | 1,855 | 2,372 | 2,448 | 2,759 | 2,759 | 2,901 | 3,187 | 3,244 | |
Total Assets | 2,624 | 3,242 | 3,602 | 3,983 | 4,814 | 5,350 | 6,459 | 7,360 | 8,103 | 8,596 | 9,166 | 11,289 | 10,309 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
91 | 199 | 259 | 387 | 443 | 373 | 470 | 597 | 623 | 537 | 905 | 1,293 | |
-271 | -202 | -441 | -468 | -733 | -356 | -759 | -888 | -1,152 | -405 | -711 | -289 | |
139 | 227 | 47 | 135 | 373 | -63 | 392 | 330 | 477 | -108 | -215 | -910 | |
Net Cash Flow | -40 | 224 | -136 | 54 | 83 | -46 | 103 | 39 | -52 | 24 | -20 | 94 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
ROCE % | 9% | 11% | 13% | 14% | 13% | 12% | 12% | 9% | 8% | 7% | 10% | 14% |
Debtor Days | 39 | 40 | 42 | 45 | 46 | 44 | 43 | 36 | 38 | 37 | 39 | 33 |
Inventory Turnover | 8.13 | 7.91 | 9.09 | 9.24 | 9.39 | 8.99 | 8.51 | 8.40 | 8.54 | 8.13 | 8.42 | 8.64 |
Documents
Add documentRecent announcements
- Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate 26 Feb
- Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate 23 Feb
- Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011. 16 Feb
- Limited Review Report On Unaudited Financial Results For The Quarter And Nine Months Ended December 31, 2020 With UDIN. 12 Feb
- Termination Of Global Depository Receipts ("Gdrs") Program And Delisting Of Gdrs From The Luxembourg Stock Exchange ("LSE") 12 Feb
View all
Annual reports
- Financial Year 2020 from bse
- Financial Year 2019 from bse
- Financial Year 2017 from bse
- Financial Year 2016 from bse
- Financial Year 2015 from bse
- Financial Year 2014 from bse
- Financial Year 2013 from bse
- Financial Year 2012 from bse
- Financial Year 2011 from bse
- Financial Year 2011 from nse
- Financial Year 2010 from bse
- Financial Year 2010 from nse